C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/06 (2006.01) A61K 31/404 (2006.01) A61P 3/06 (2006.01) C07D 209/08 (2006.01) C07D 209/12 (2006.01) C07D 209/30 (2006.01) C07D 401/06 (2006.01) C07D 403/06 (2006.01) C07D 409/06 (2006.01) C07D 413/10 (2006.01) C07D 417/06 (2006.01)
Patent
CA 2564563
Compounds of formula (I) (see formula I) or pharmaceutically acceptable salts or pharmaceutically acceptable esters thereof, wherein R1, R2, R3, R4, R5, R6, A, m, n and p are defined as in claim 1. These compounds can be used as medicaments in the treatment of diseases such as atherosclerosis and diabetes.
L'invention concerne des composés représentés par la formule (I) ainsi que des sels pharmaceutiquement acceptables et des esters pharmaceutiquement acceptables de celle-ci, dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿, A, m, n et p sont tels que définis dans la revendication 1. Ces composés peuvent être utilisés en tant que médicaments dans le traitement de maladies telles que l'athérosclérose et le diabète.
Dehmlow Henrietta
Kuhn Bernd
Panday Narendra
Ratni Hasane
Schulz-Gasch Tanja
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Indolyl derivatives as liver-x-receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolyl derivatives as liver-x-receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl derivatives as liver-x-receptor modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1615992